Coagulation Disorders near Riverview, FL
We found 56 results within 10 miles for "Coagulation Disorders near Riverview, FL"
- Listened/answered questions (6)
- Explains conditions well (6)
- Appt. wasn't rushed (5)
- Offers Telehealth
Care Philosophy: Gustavo Rivero, MD, is a dual fellowship-trained hematology and medical oncologist specializing in the treatment of acute and chronic leukemia. Dr Riveros areas of clinical expertise includes: acute and chronic myeloid leukemias, acute lymphoid leukemias, myelodysplastic syndrome, myeloproliferative neoplasm, and clonal hematopoiesis of indetermined potential (CHIP).

- Appt. wasn't rushed (12)
- Listened/answered questions (12)
- Explains conditions well (12)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: ``Out in the community, it's rare that you would have a medical, radiation, and surgical oncologist who see just genitourinary cancers as we do.`` Dr. Mayer Fishman is a genitourinary oncologist and a member of the immunotherapy and experimental therapeutics programs at Moffitt Cancer Center. He is also an associate professor on oncology and internal medicine at the University of South Florida College of Medicine.

- Explains conditions well (42)
- Found trustworthy (42)
- Listened/answered questions (41)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (3)
- Listened/answered questions (3)
- Explains conditions well (3)
- View 1 more provider attributes
Care Philosophy: Dr. Fletcheris an Associate Professor of Medicine within the Division of Hematology and Oncology. He is a Veterans Administration Advanced Career Development Awardee, American Heart Association Career Development Awardee and Florida Biomedical Research Program NIR Awardee.

- Found trustworthy (26)
- Appt. wasn't rushed (25)
- Listened/answered questions (25)
- View 2 more provider attributes
- Offers Telehealth

- Found trustworthy (84)
- Listened/answered questions (82)
- Explains conditions well (82)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (5)
- Listened/answered questions (5)
- Explains conditions well (5)
- View 2 more provider attributes

- Explains conditions well (6)
- Felt Respected (1)
- Offers Telehealth

- Listened/answered questions (2)
- Explains conditions well (2)
- Found trustworthy (2)
- View 1 more provider attributes
- Offers Telehealth

- Listened/answered questions (6)
- Explains conditions well (6)
- Appt. wasn't rushed (5)
- Offers Telehealth
Care Philosophy: Gustavo Rivero, MD, is a dual fellowship-trained hematology and medical oncologist specializing in the treatment of acute and chronic leukemia. Dr Riveros areas of clinical expertise includes: acute and chronic myeloid leukemias, acute lymphoid leukemias, myelodysplastic syndrome, myeloproliferative neoplasm, and clonal hematopoiesis of indetermined potential (CHIP).

- Found trustworthy (10)
- Appt. wasn't rushed (9)
- Listened/answered questions (9)
- View 2 more provider attributes
- Offers Telehealth

- Appt. wasn't rushed (27)
- Listened/answered questions (27)
- Explains conditions well (27)
- View 2 more provider attributes
- Offers Telehealth

Care Philosophy: Dr. Naraev believes in compassionate, personalized care that is focused on his patients, their hopes, needs and quality of life.

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes


- Listened/answered questions (35)
- Explains conditions well (35)
- Appt. wasn't rushed (2)
- View 1 more provider attributes
- Offers Telehealth
Care Philosophy: We work as a team to make sure that every patient receives the highest quality, most effective treatment available today. That's especially true for prostate cancer patients, where there are so many options. For us, treating prostate cancer is not only about curing the disease, but assuring each patient's long term quality of life. Toward that end, I establish open communications with my patients, for their ease of access and peace of mind from diagnosis through recovery.

- Listened/answered questions (2)
- Explains conditions well (2)
- Appt. wasn't rushed (1)
- View 2 more provider attributes
- Offers Telehealth
Care Philosophy: At Florida Cancer Specialists & Research Institute you will find experienced and compassionate doctors you can trust to treat your unique cancer. Our physicians share a passion for delivering exceptional and personalized care for all forms of cancer and blood disorders, close to home. From genetic screening to immunotherapies and access to clinical trials, our top-ranked cancer experts provide the newest and most advanced treatments available increasing cure rates and extending lives. No other community-based oncology practice in Florida matches the clinical trial opportunities we offer. The majority of new cancer drugs approved for use in the U.S. in recent years were studied in clinical trials with FCS participation, prior to approval. Every interaction is focused on each patient's experience and well-being to minimize disruption to daily life. Beginning with your first appointment, our dedicated FCS team provides expert guidance and support at every step of your cancer journey.

- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Noman Ashraf, MD is an Oncology Specialist who practices in Tampa, FL. He is 45 years old. Dr. Noman Ashraf, MD is affiliated with Tampa General Hospital and Tampa General Hospital.


- Appt. wasn't rushed (2)
- Listened/answered questions (2)
- Explains conditions well (2)
- View 1 more provider attributes
- Offers Telehealth

- Explains conditions well (40)
- Found trustworthy (40)
- Listened/answered questions (39)
- View 2 more provider attributes
- Offers Telehealth
Biography: Dr. Vaagn Andikyan, MD is an Obstetrics /amp Gynecology Specialist who practices in Tampa, FL. He is 47 years old and has been practicing for 23 years. Dr. Vaagn Andikyan, MD is affiliated with Tampa General Hospital and Tampa General Hospital.

- Appt. wasn't rushed (1)
- Listened/answered questions (1)
- Explains conditions well (1)
- View 1 more provider attributes

- Offers Telehealth

- Appt. wasn't rushed (4)
- Listened/answered questions (4)
- Explains conditions well (4)
- View 1 more provider attributes
- Offers Telehealth
Biography: Dr. Sotomayor is the director of the newly established Cancer Institute at Tampa General Hospital. He is a pioneer in the field of cancer immunology and immunotherapy and an internationally renowned expert in lymphoma research and treatment. Prior to joining Tampa General, he was the director of the George Washington University Cancer Center with responsibility and authority over all aspects of cancer care and research at GW and affiliated health systems. He was also a professor of medicine in the division of hematology/oncology at George Washington University School of Medicine and Health Sciences. Fluent in English and Spanish, Dr. Sotomayor specializes in the treatment of lymphomas and leukemias. The accomplished physician-scientist's ongoing research is directed toward cancer immunology and immunotherapy with special focus in developing novel immune-based approaches for the treatment of lymphomas and other hematologic malignancies. Considered as a world expert in mantle cell lymphoma (MCL), he has more than 140 publications including seminal discoveries published in top tier journals such as Nature Immunology, Nature Medicine, Blood, Proceedings of the National Academy of Sciences, Cancer Cell among others. He has been the recipient of several awards, including the recipient of the National Cancer Institute (NCI) CURE Lifetime Achievement award in 2017. Dr. Sotomayor is involved in several major medical societies and organizations and currently is a member of the Scientific Advisory Board, Lymphoma Research Foundation, member of the Executive Committee of the Mantle Cell Lymphoma Consortium and member of several committees of the American Association for Cancer Research (AACR). He has also served in committees at the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO) and the National Cancer Institute (NCI)
